296 related articles for article (PubMed ID: 29056013)
1. [Clinical study of non-alcoholic fatty liver disease and its combined the chronic HBV infection].
He J; Zeng YL; Li W; Guo EE; Li JL; Kang Y; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):618-622. PubMed ID: 29056013
[No Abstract] [Full Text] [Related]
2. [Study of reactive oxygen species and adiponectin for chronic HBV infection combined with nonalcoholic fatty liver diseases].
Xu L; Zhong Y; Su ST; Liu YG; Lyu FN; Zhou XL; Ren JQ; Li P; Shi RF; Jiang Y; Fan JG; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):247-253. PubMed ID: 32306658
[No Abstract] [Full Text] [Related]
3. Relations of hepatic steatosis with liver functions, inflammations, glucolipid metabolism in chronic hepatitis B patients.
Chen XL; Han YD; Wang H
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5640-5646. PubMed ID: 30229840
[TBL] [Abstract][Full Text] [Related]
4. [Quantitative detection and clinical value of CD44 in patients with nonalcoholic fatty liver disease].
Fang M; Yao M; Yang JL; Wang L; Sun JY; Wu MN; Yao DF; Tai BJ
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):994-1000. PubMed ID: 31941262
[No Abstract] [Full Text] [Related]
5. Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis.
Zheng RD; Chen JN; Zhuang QY; Lu YH; Chen J; Chen BF
Int J Med Sci; 2013; 10(5):641-6. PubMed ID: 23569427
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis.
Li H; Xu QY; Xie Y; Luo JJ; Cao HX; Pan Q
Ann Hepatol; 2021; 24():100316. PubMed ID: 33515803
[TBL] [Abstract][Full Text] [Related]
7. [Establishment and identification of non-alcoholic fatty liver disease in chronic hepatitis B virus infected mice].
Zhang Z; Pan Q; Duan XY; Shi JP; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):658-63. PubMed ID: 22152379
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model.
Hu D; Wang H; Wang H; Wang Y; Wan X; Yan W; Luo X; Ning Q
Hepatol Int; 2018 Sep; 12(5):438-446. PubMed ID: 29974410
[TBL] [Abstract][Full Text] [Related]
9. Comparing hepatic steatosis distribution patterns between non-alcoholic fatty liver disease and fatty liver disease with chronic hepatitis B by second-harmonic generation/two-photon excited fluorescence method.
Zhuang Z; Qu H; Yang W; Liu J; Wang F; Liu Y; Ding J; Shi J
Ann Hepatol; 2020; 19(3):313-319. PubMed ID: 31870745
[TBL] [Abstract][Full Text] [Related]
10. Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis.
Zheng RD; Xu CR; Jiang L; Dou AX; Zhou K; Lu LG
Int J Med Sci; 2010 Aug; 7(5):272-7. PubMed ID: 20714438
[TBL] [Abstract][Full Text] [Related]
11. [Exploring the effects of entecavir treatment on the degree of liver fibrosis in patients with non-alcoholic fatty liver combined with chronic hepatitis B in Tibet region].
Wen QP; Qian H; Ba S; Lu MJ; Silang LDJ; Shi L
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):304-308. PubMed ID: 35462487
[No Abstract] [Full Text] [Related]
12. Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children.
Wang L; Lu C; Zhang Y; Liang Q; Zhang J
BMC Gastroenterol; 2024 Jan; 24(1):2. PubMed ID: 38166674
[TBL] [Abstract][Full Text] [Related]
13. [Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads].
Shi JP; Fan JG; Lou GQ; Zhang L; Hu CB; Wu R; Xun YH
Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):818-22. PubMed ID: 19032864
[TBL] [Abstract][Full Text] [Related]
14. [Model building-up and observation on the mouse carried chronic hepatitis B and nonalcoholic fatty liver disease].
Lu L; Liu YL; Yang WJ; Liu J; Luo Y; Zhuang ZJ; Chen JY; Bian DX; Xun YH; Shi JP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):332-5. PubMed ID: 24645315
[TBL] [Abstract][Full Text] [Related]
15. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of clinical characteristics and risk factors of hepatic fibrosis in children with chronic hepatitis B combined with metabolic-related fatty liver disease].
Li W; Jiang LN; Zhao BK; Liu HY; Zhao JM
Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):601-607. PubMed ID: 37400384
[No Abstract] [Full Text] [Related]
17. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
18. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
[TBL] [Abstract][Full Text] [Related]
19. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
20. Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).
Fernández Rodríguez CM; Aller R; Gutiérrez García ML; Ampuero J; Gómez-Camarero J; Martín-Mateos RMª; Burgos-Santamaría D; Rosales JM; Aspichueta P; Buque X; Latorre M; Andrade RJ; Hernández-Guerra M; Romero-Gómez M
Rev Esp Enferm Dig; 2019 Apr; 111(4):264-269. PubMed ID: 30810330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
